You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

MYKROX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Mykrox patents expire, and when can generic versions of Mykrox launch?

Mykrox is a drug marketed by Chartwell Molecular and is included in one NDA.

The generic ingredient in MYKROX is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mykrox

A generic version of MYKROX was approved as metolazone by SANDOZ on December 19th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MYKROX?
  • What are the global sales for MYKROX?
  • What is Average Wholesale Price for MYKROX?
Summary for MYKROX
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 87
Patent Applications: 4,010
DailyMed Link:MYKROX at DailyMed
Drug patent expirations by year for MYKROX

US Patents and Regulatory Information for MYKROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecular MYKROX metolazone TABLET;ORAL 019532-001 Oct 30, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.